Category : Search result: pharmaceutical stocks


US Stock Market Crash Fears: Experts Divided

Is the US stock market heading for a crash? Experts are divided as S&P 500 gains 16% and Nasdaq surges 20% YTD. Learn about the risks and opportunities for Indian investors.

Sudeep Pharma IPO Allotment Status Today

Sudeep Pharma IPO allotment finalized today after massive 93.71x subscription. GMP at ₹87 signals 14.67% listing gain. Track your allotment status now!

Sudeep Pharma IPO Subscribed 94 Times

Sudeep Pharma's ₹895 crore IPO witnessed massive demand, subscribed 94 times. QIB portion booked 213x. Shares may list at a 14% premium. Key details inside.

Ramaswamy's net worth jumps 80% to $1.8 billion

Indian-American billionaire Vivek Ramaswamy's fortune surges to $1.8B despite political setbacks. Discover how his pharma investments fueled this remarkable growth and his Ohio governor campaign.

Balaxi Pharma Soars 10% Despite 47% Yearly Loss

Balaxi Pharmaceuticals shares surged 10% to ₹39.5 in intraday trade Friday, defying market weakness. However, the stock remains down 47.42% YTD with retail investors facing significant wealth erosion.

Australian shares hit 5-month low in market sell-off

Australian shares plummeted to five-month lows as mining, banking, and technology stocks faced heavy losses. The S&P/ASX 200 index dropped 1.6% amid global valuation concerns. Read full analysis.

Sudeep Pharma IPO: 22% GMP, Opens Nov 21

Sudeep Pharma's ₹95 crore IPO opens November 21 with strong grey market premium. Learn price band, dates, financials & investment details for this pharma ingredients maker.

Evexia Lifecare Share Price Rises 3% on High Volumes

Evexia Lifecare share price gained over 3% with heavy trading volumes. Discover the Q2 FY26 results showing a sharp profit fall and the stock's long-term decline. Read analysis before investing.

Hvax Technologies H1 FY26 Income Jumps 35%

Hvax Technologies announces impressive 35% growth in total income for H1 FY26, reaching ₹5.95 crore. The company shows strong financial performance with significant profit improvements.

Page 1 of 4